According to a recent analysis by market research firm Numerator, Ozempic users have slashed snack buying at supermarkets.
The food industry is still uneasy about the American anti-obesity craze, which is being fueled by GLP-1-based weight-loss medications like Wegovy and Mounjaro, which are manufactured by Novo Nordisk and Eli Lilly. This is because a recent study, which was cited by Morgan Stanley, indicates that households taking these medications are spending less money at the grocery store.
According to data provided by the recruiting website Glassdoor, the best places to work in America in 2024 are Bain & Company and Nvidia.
According to a recent analysis by market research firm Numerator, households taking GLP-1 medications spent 6% to 9% less each month on groceries than households not taking GLP-1 medications.
Sales of snacks, pastries, and ice cream decreased, but purchases of fish, veggies, and yogurt climbed in many GLP-1 homes.
According to MS, the ...
Full Access
Included:
-
Access to All Articles.
-
One Plan. No Tiers.
-
No Ads.
-
Cancel anytime.
